9YR企业会员
发布人:长沙上禾生物科技有限公司
发布日期:2022/4/20 21:31:27
博落回提取物:取博落回果颊,经过提取纯化而得,主要成分为博落回总碱60%(血根碱和白屈菜红碱),可用于饲料添加剂和生物农药,作为饲料添加剂,可代替抗生素,是纯天然的饲料添加剂。
博落回提取物是从 科植物博落回的果实经加工制成的橘黄色粉末,含血根碱和白屈菜红碱的总量不少于60.0%,具有抗菌消炎、开胃和促生长作用,主要用于促进猪、鸡生长。
博落回(Macleaya cordata)系 科植物,俗称号筒杆、山号筒、落回,在我国药用已有一千多年历史,药用其带根全草,味辛、苦,性温,有大毒,功用解毒、消肿、杀虫,主治疔毒脓肿,恶疮溃疡,烫伤,疥癣等。近代药理研究表明,博落回主要活性成分为生物碱成分,具有抗菌、抗肿瘤、消肿、杀虫杀蛆、止咳平喘、改善肝功能等作用。民间主要用于疔疮痈肿、阴道滴虫、跌打损伤、脚癣、湿疹等的治疗。近代研究表明博落回中的生物碱具有很好的抗病毒性肝炎等的作用。
Basic information:
Product Name: Macleaya Cordata Extract
Latin Name: Macleaya cordata (Willd.)R.Br.
Part Used: Whole Herb
Appearance: Orange fine powder
Active Ingredient: Sanguinarine+chelerythrine
Specification: 10%-60%
Test Method: HPLC
Odor&Taste:Characteristic
Grade:Pharmaceutical and Food
What is Macleaya Cordata Extract?
Macleaya cordata extract powder is a bloodroot which owns thousand-year history of medicinal usage in China. 13 kinds of alkaloids and other compounds such as sanguinarine, toddaline, protopine, a-allocryptopine, bocconine, rhizoma coptidis alkali, berberine, samin alkali and protopine are in the root and aerial parts. Macleaya cordata extract contains sanguinaine and chelerythrine, which have fungicidal and insecticidal activity. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. Macleaya cordata contains several alkaloids including sanguinarine, chelerythrine, protopine, and allocryptopine. Our product, Macleaya cordata extract mainly constains with sanguinarine and chelerythrine. It was been show to be reversible inhibitors of the enzymatic hydrolysis of acetylthiocholine.
Function:
1.Strong bactericidal and antibacterial activity;
2.Anti-inflammatory;
3.Fungicidal and insecticidal;
4.Antioxidant properties;
5.Anti-cancer and treating prostate cancer;
Application:
1.It is widely used in veterinary medicine filed.
2.It is widely used in feed additive field.
3.It is widely used in medicine field.
4.It is widely used in cosmetic field.
发布于 2020-02-19 23:13
赞同
添加评论
分享
喜欢收藏申请转载
相关新闻资讯